))
Episode 107: The Skinny on GLP-1 Drugs
Manage episode 469196717 series 3640645
محتوای ارائه شده توسط Mark and Joe. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Mark and Joe یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
You know them by their brand names, like Ozempic, Trulicity, or Mounjaro. They're the GLP-1 receptor agonists that were originally formulated for Type 2 diabetes but have caused a revolution in the treatment of weight loss. As more research rolls in, they’re also looking like game-changers for treating conditions as far-ranging as heart disease, dementia, and substance use disorders. Do they represent a medical breakthrough on the level of penicillin, or are they too good to be true? Joe and Mark review the pros and cons and consider how some things in life can be truly double-edged swords. (Recorded February 28, 2025.)
109 قسمت
اشتراک گذاری
